Honokiol, a chemopreventive agent against skin cancer, induces cell cycle arrest and apoptosis in human epidermoid A431 cells

Experimental Biology and Medicine

Volumn 236, Issue 11, 2011, Pages 1351-1359

  Chilampalli, Chandeshwari ^a   Guillermo, Ruth ^a   Kaushik, Radhey S ^a   Young, Alan ^a   Chandrasekher, Gudiseva ^a   Fahmy, Hesham ^a   Dwivedi, Chandradhar ^a  

^a SOUTH DAKOTA STATE UNIVERSITY   (United States)

Author keywords

Apoptosis; Cell cycle; Honokiol

Indexed keywords

CYCLIN D1; CYCLIN D2; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; CYCLIN DEPENDENT KINASE 6; GAG PROTEIN; HONOKIOL; PROTEIN P21;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CELL CYCLE ARREST; CONCENTRATION RESPONSE; CONTROLLED STUDY; DNA FRAGMENTATION; DOWN REGULATION; DRUG EFFECT; DRUG MECHANISM; HUMAN; HUMAN CELL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; UPREGULATION;

ANIMALS; ANTICARCINOGENIC AGENTS; APOPTOSIS; BIPHENYL COMPOUNDS; CARCINOMA, SQUAMOUS CELL; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CELL PROLIFERATION; CYCLIN D1; CYCLIN D2; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASE 6; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLIN-DEPENDENT KINASE INHIBITOR P27; DNA FRAGMENTATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIGNANS; MICE; SKIN NEOPLASMS;

MAGNOLIA OFFICINALIS; MUS;

EID: 80055102706     PISSN: 15353702     EISSN: 15353699     Source Type: Journal    
DOI: 10.1258/ebm.2011.011030     Document Type: Article

References (31)

1. Tsai TH, Chen CF. Identification and determination of honokiol and magnolol from Magnolia Officinalis by high-performance liquid chromotagraphy with photodiode-array UV detection. J Chromatogr A 1992;598:143-6
2. Clark AM, El-Feraly FS, Li WS. Antimicrobial activity of phenolic constituents of Magnolia grandiflora L. J Pharm Sci 1981;70:951-2
3. Liou KT, Shen YC, Chen CF, Tsao CM, Tsai SK. Honokiol projects rat brain from focal cerebral ischemia-reperfusion injury by inhibiting neutrophil infiltration and reactive oxygen species production. Brain Res 2003;992:159-66
4. Chen F, Wang T, Wu YF, Gu Y, Xu XL, Zheng S, Hu X. Honokiol: a potent chemotherapy candidate for colorectal carcinoma. World J Gastroenterol 2004;10:3459-63
5. Wang T, Chen F, Chen Z, Wu YF, Xu XL, Zheng S, Hu X. Honokiol induces apoptosis through p53-independent pathway in human colorectal cell line RKO. World J Gastroenterol 2004;10:2205-8
6. Wolf I, O'Kelly J, Wakimoto N, Nguyen A, Amblard F, Karlan BY, Arbiser JL, Koeffler HP. Honokiol, a natural biphenyl, inhibits in vitro and in vivo growth of breast cancer through induction of apoptosis and cell cycle arrest. Int J Oncol 2007;30:1529-37
7. Hahm ER, Singh SV. Honokiol causes G0-G1 phase cell cycle arrest in human prostate cancer cells in association with suppression of retinoblastoma protein level/phosphorylation and inhibition of E2F1 transcriptional activity. Mol Cancer Ther 2007;6:2686-95
8. Ahn KS, Sethi G, Shishodia S, Sung B, Arbiser JL, Aggarwal BB. Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-kappaB activation pathway. Mol Cancer Res 2006;4:621-33
9. Konoshima T, Kozuka M, Tokuda H, Nishino H, Iwashima A, Haruna M, Ito K, Tanabe M. Studies on inhibitors of skin tumor promotion, IX. Neolignans from Magnolia officinalis. J Natl Prod 1991;54:816-22
10. Chilampalli S, Zhang X, Fahmy H, Kaushik SR, Zeman D, Hildreth M, Dwivedi C. Chemopreventive effects of honokiol on UVB-induced skin cancer development. Anticancer Res 2010;30:777-84
11. Lu YP, Lou YR, Xie JG, Peng QY, Liao J, Yang CS, Huang MT, Conney AH. Topical applications of caffeine or (-)-epigallocatechin gallate (EGCG) inhibit carcinogenesis and selectively increase apoptosis in UV B-induced skin tumors in mice. Proc Natl Acad Sci USA 2002;99:12455-60
12. Gu M, Singh RP, Dhanalakshmi S, Agarwal C, Agarwal R. Silibinin inhibits inflammatory and angiogenic attributes in photocarcinogenesis in SKH-1 hairless mice. Cancer Res 2007;67:3483-91
13. Vaid M, Sharma SD, Katiyar SK. Honokiol, a phytochemical from the Magnolia plant, inhibits photocarcinogenesis by targeting UVB-induced inflammatory mediators and cell cycle regulators: development of topical formulation. Carcinogenesis 2010;31:2004-11
14. Donzelli M, Draetta GF. Regulating mammalian checkpoints through Cdc25 inactivation. EMBO Rep 2003;4:671-7
15. Sun SY, Hail NJ, Lotan R. Apoptosis as a novel target for cancer chemoprevention. J Natl Cancer Inst 2004;96:662-72
16. Wattenberg LW. Chemoprevention of cancer. Cancer Res 1985;45:1-8
17. Paveltich NP. Mechanism of cyclin-dependent kinase regulation: structures of cdks, their cyclin activators, and CIP and INK4 inhibitiors. J Mol Biol 1999;287:821-8
18. Grana X, Reddy P. Cell cycle control in mammalian cells; role of cyclins, a cyclin-dependent kinases (CDK's), growth suppressor genes and cyclin-dependent kinase inhibitors (CDKI). Oncogene 1995;11:211-9
19. Pinto AE, Andre S, Laranjerira C, Soares J. Correlations of cell cycle regulators (p53, p21, prb and mdm2) and c-erB-2 with biological markers of proliferation and overall survival in breast cancer. Pathology 2005;37:45-50
20. Li W, Sanki A, Karim RZ, Thompson JF, Soon Lee C, Zhuang L, Mc Carthy SW, Scolyer RA. The role of cell cycle regulatory proteins in the pathogenesis of melanoma. Pathology 2006;38:287-301
21. Michalides RJ. Cell cycle regulators: mechanisms and their role in aetiology, prognosis, and treatment of cancer. J Clin Pathol 1999;52:555-68
22. Jo H, Song JD, Kim KM, Cho YH, Kim KH, Park YC. Diallyl disulfide induces reversible G2/M phase arrest on a p53- independent mechansism in human colon cancer KCT-116 cells. Oncol Rep 2008;19:275-80
23. Toyoshima H, Hunter T. p27, a novel inhibitor of Gl cyclin-CDK protein kinase activity, is related to p21. Cell 1994;78:67-74
24. Ahn KS, Sethi G, Shishodia S, Sung B, Arbiser JL, Agarwal B. Honokiol potentiates apoptosis, suppresses osteoclastogenesis and inhibits invasion through modulation of nuclear factor-kB activation pathway. Mol Cancer Res 2006;4:621-33
25. Leeman-Neill RJ, Cai Q, Joyce SC, Thomas SM, Bhola NE, Neill DB, Arbiser JL, Grandis JR. Honokiol inhibits epidermal growth factor receptor signaling and enhances the antitumor effects of epidermal growth factor receptor inhibitors. Clin Cancer Res 2010;16:2571-9
26. Molinari M. Cell cycle check points and their inactivation in human cancer. Cell Prolif 2000;33:261-74
27. Mantena SK, Sharma SD, Katiyar SK. Berberine inhibits growth, induces G1 arrest and apoptosis in human epidermoid carcinoma A431 cells by regulating Cdki-Cdk-cyclin cascade, disruption of mitochondrial membrane potential and cleavage of caspase 3 and PARP. Carcinogenesis 2006;27:2018-27
28. Meeran SM, Katiyar SK. Grape seed proanthocyanidins promote apoptosis in human epidermoid carcinoma A431 cells through alterations in Cdki-Cdk-cyclin cascade, and caspase-3 activation via loss of mitochondrial membrane potential. Exp Dermatol 2007;16:405-15
29. Pilat MJ, Kamradt JM, Pienta KJ. Hormone resistance in prostrate cancer. Cancer Metastatsis Rev 1998;17:373-81
30. Zhang X, Bommareddy A, Chen W, Khalifa S, Kaushik RS, Fahmy H, Dwivedi C. Sarcophine-diol, a chemopreventive agent of skin cancer inhibits cell growth and induces apoptosis through extrinsic pathway in human epidermoid carcinoma A431 cells. Transl Oncol 2009;2:21-30
31. Ouhtit A, Gorny A, Muller HK, Hill L, Owen-schaub L, Ananthaswamy HN. Loss of fas-ligand expression in mouse keratinocytes during UV carcinogenesis. Am J Pathol 2009;157:1975-81